Patents for C07K 19 - Hybrid peptides (29,428) |
---|
07/11/2012 | CN102558313A Enterovirus 71 type specific recombinant protein antigen and application thereof |
07/11/2012 | CN102558306A Antigen epitope for preventing and treating trichinosis, composition thereof and application thereof |
07/11/2012 | CN102558300A Polypeptides capable of antagonizing corticotropin-releasing factor receptors 1 and application of polypeptides |
07/11/2012 | CN102552904A Recombinant molecule of human immunodeficiency virus film molecule gp120 functional domain and human TGF (Transforming Growth Factor)-beta1 |
07/11/2012 | CN102552902A Preparation method of dendritic cell vaccine loaded with recombinant human gp96-Ki67 antigen peptide compound |
07/11/2012 | CN101081870B Antineoplastic biological medicament PTD4-GFP-Apoptin fusion protein and preparation method thereof |
07/10/2012 | US8216805 Knobs and holes heteromeric polypeptides |
07/10/2012 | US8216586 Lipases and uses thereof |
07/10/2012 | US8216569 Vascular endothelial growth factor 2 |
07/10/2012 | CA2510893C Binding agents which inhibit myostatin |
07/10/2012 | CA2435712C Universal carrier for targeting molecules to gb3 receptor expressing cells |
07/10/2012 | CA2306450C Polypeptides and nucleic acids encoding same |
07/10/2012 | CA2211324C Recombinant human alpha-fetoprotein and uses thereof |
07/10/2012 | CA2194172C Neurturin and related growth factors |
07/05/2012 | WO2012089164A1 Functional construction of secb-mediated post-translational targeting pathway and use thereof |
07/05/2012 | WO2012088739A1 Method for preparing fusion protein of mycobacterium tuberculosis antigens and uses thereof |
07/05/2012 | WO2012088608A1 Compositions comprising natriuretic peptides and methods of use thereof |
07/05/2012 | WO2012054008A9 Methods and compositions comprising tau oligomers |
07/05/2012 | WO2012050921A3 Nd2 peptides and methods of treating neurological disease |
07/05/2012 | WO2012024558A3 Light mediated regulation of protein dimerization |
07/05/2012 | WO2012015938A3 Obligate heterodimer variants of foki cleavage domain |
07/05/2012 | US20120172578 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
07/05/2012 | US20120172303 Growth Hormones with Prolonged In-Vivo Efficacy |
07/05/2012 | US20120172254 Methods and compositions for diagnostic assays for measuring cell mediated immune response |
07/05/2012 | US20120172235 Peptide libraries |
07/05/2012 | US20120171747 Signal amplification microspheres, their use in one-step and multi-step analytical amplification procedures and methods for their production |
07/05/2012 | US20120171674 Detection of Cells Expressing T1R2 Taste Receptor |
07/05/2012 | US20120171236 Immunization against chlamydia pneumoniae |
07/05/2012 | US20120171205 Galectin-Immunoglobulin Chimeric Molecules |
07/05/2012 | US20120171204 Compositions and methods for the treatment and diagnosis of immune disorders |
07/05/2012 | US20120171203 Activin receptor-like kinase-1 compositions and methods of use |
07/05/2012 | CA2834402A1 Clostridium difficile antigens |
07/05/2012 | CA2823066A1 Compositions comprising natriuretic peptides and methods of use thereof |
07/04/2012 | EP2471915A1 Modified peptide vaccine derived from influenza m2 |
07/04/2012 | EP2471819A2 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof |
07/04/2012 | EP1472238B1 Bioluminescent protease assay |
07/04/2012 | CN1525981B T1R taste receptors and genes encoding same |
07/04/2012 | CN1416467B Zinc finger domains and methods of identifying same |
07/04/2012 | CN102549012A Method for purifying albumin |
07/04/2012 | CN102533839A Method for performing fusion expression on protein containing disulfide bond |
07/04/2012 | CN102533627A Functional construction and application of SecB-mediated translated targeted path |
07/04/2012 | CN102532326A Tumor-targeted plasminogen Kringle5 variant and application thereof |
07/04/2012 | CN102532325A Method for preparing cecropins AD and frog Buforin II fusion antimicrobial peptide by using hydroxylamine cutting method, and uses thereof |
07/04/2012 | CN102532324A Preparation and application of brucella gene engineering subunit vaccines |
07/04/2012 | CN102532321A Novel antigen-binding polypeptides and their uses |
07/04/2012 | CN102532284A A mutated immunoglobulin-binding protein |
07/04/2012 | CN102532280A HIV (human immunodeficiency virus) immunogen and preparation thereof |
07/04/2012 | CN102526726A Myoglobin immunoadsorbent and immunoadsorption device |
07/04/2012 | CN102121023B Mutant human plasminogen kringle5, preparation method and application thereof |
07/04/2012 | CN102061303B Fusion expression product of antimicrobial peptide genes of two marine animals and preparation method of fusion expression product |
07/04/2012 | CN101979505B Method and special engineering bacteria for producing N-terminal acetyl protein or polypeptide |
07/04/2012 | CN101955545B Multi-target recombination gene and application of protein thereof in preventing and treating infection of helicobacter pylori |
07/04/2012 | CN101942025B Heparanase III fusion protein and coding gene and expression method thereof |
07/04/2012 | CN101942024B Heparanase II fusion protein and coding gene and expression method thereof |
07/04/2012 | CN101921800B Escherichia coli protein expression vector using trigger factor as fusion tag and construction method and application thereof |
07/04/2012 | CN101891826B Targeted hIL-10 recombinant protein and application thereof |
07/04/2012 | CN101798351B Recombinant expression of human TIM-1-Fc fusion protein |
07/04/2012 | CN101736006B Method for recombinant expression of soluble transcription mediator complex Med23 subunit |
07/04/2012 | CN101503474B Human vascular endothelial cell growth inhibition factor jogged polypeptide, preparation thereof and use in targeted antineoplastic activity |
07/04/2012 | CN101463089B Human serum albumin-interferon fusion protein, and encoding gene and use thereof |
07/04/2012 | CN101321870B Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
07/04/2012 | CN101302255B Matrix metalloproteinase targeted recombined human tumor necrosis factor and preparation thereof |
07/03/2012 | US8212003 Bifunctional fusion protein with thrombolytic and anticoagulant activities and uses thereof |
07/03/2012 | US8211671 Activatable recombinant neurotoxins |
07/03/2012 | US8211658 Complex of a chaperone with β-amyloid and methods employing this complex |
07/03/2012 | US8211655 Wild-type receptor assays |
07/03/2012 | US8211439 Albumin fusion proteins comprising insulin polypeptides |
07/03/2012 | CA2640956C B7rp-1 polypeptides |
07/03/2012 | CA2522248C Methods of treatment using specific binding agents of human angiopoietin-2 |
07/03/2012 | CA2445577C Subcellular targeting of therapeutic proteins |
07/03/2012 | CA2406132C Ligand for herpes simplex virus entry mediator and methods of use |
07/03/2012 | CA2296711C Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
07/02/2012 | CA2806314A1 Method for purifying active polypeptides or immunoconjugates |
06/28/2012 | WO2012087966A2 Targeted perhydrolases |
06/28/2012 | WO2012087943A2 Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction |
06/28/2012 | WO2012087835A2 Compositions and methods for enhancing protein folding |
06/28/2012 | WO2012086647A1 Fusion protein |
06/28/2012 | WO2012084272A1 Oprf/i agents and their use in hospitalized and other patients |
06/28/2012 | WO2012083445A1 Virus like particle production in plants |
06/28/2012 | WO2012053828A9 Human interleukin-1 receptor antagonist - hybrid fc fusion protein |
06/28/2012 | WO2012037397A3 Step-derived peptide for brain injury treatment |
06/28/2012 | WO2012033382A3 Novel rna-binding protein and label-free detection method for detecting microrna using same |
06/28/2012 | US20120167238 Universal peptide tags for transgene polypeptide analysis by mass spectrometry |
06/28/2012 | US20120165511 Protein purification using hcic and ion exchange chromatography |
06/28/2012 | US20120165272 Tear Substitutes |
06/28/2012 | US20120165269 Tumor Cell-Killing Peptides |
06/28/2012 | US20120165268 P53 fusion proteins and methods of making and using thereof |
06/28/2012 | US20120165226 Phage display |
06/28/2012 | US20120164727 Productivity augmenting protein factor, novel cell lines and uses thereof |
06/28/2012 | US20120164664 T1r taste receptors and genes encoding same |
06/28/2012 | US20120164164 Multimeric polypeptides of hla-g including alpha1-alpha3 monomers and pharmaceutical uses thereof |
06/28/2012 | US20120164155 Chimeric molecules |
06/28/2012 | US20120164142 Compositions comprising natriuretic peptides and methods of use thereof |
06/28/2012 | US20120164140 Hemojuvelin fusion proteins and uses thereof |
06/28/2012 | US20120164101 Gm-csf and interleukin-21 conjugates and uses thereof in the modulation of immune response and treatment of cancer |
06/28/2012 | US20120164066 Antigen-binding proteins comprising recombinant protein scaffolds |
06/28/2012 | CA2822684A1 Oprf/i agents and their use in hospitalized and other patients |
06/28/2012 | CA2822268A1 Targeted perhydrolases |
06/28/2012 | CA2821574A1 Virus like particle production in plants |
06/27/2012 | EP2467485A1 Screening of protein candidates |